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ApoptosisAbnormal accumulation of amyloid-β (Aβ) peptide in the brain is a pathological hallmark of Alzheimer's disease
(AD). In addition to neurotoxic effects, Aβ also damages brain endothelial cells (ECs) andmay thus contribute to
the degeneration of cerebral vasculature, which has been proposed as an early pathogenic event in the course of
AD and is able to trigger and/or potentiate the neurodegenerative process and cognitive decline. However, the
mechanisms underlying Aβ-induced endothelial dysfunction are not completely understood. Here we hypothe-
sized that Aβ impairs protein quality control mechanisms both in the secretory pathway and in the cytosol in
brain ECs, leading cells to death. In rat brain RBE4 cells, we demonstrated that Aβ1–40 induces the failure of the
ER stress-adaptive unfolded protein response (UPR), deregulates the ubiquitin–proteasome system (UPS) de-
creasing overall proteasome activity with accumulation of ubiquitinated proteins and impairs the autophagic
protein degradation pathway due to failure in the autophagicﬂux,which culminates in cell demise. In conclusion,
Aβ deregulates proteostasis in brain ECs and, as a consequence, these cells die by apoptosis.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Alzheimer's disease (AD) is the most frequent cause of dementia in
the elderly. One neuropathological hallmark of AD is the extracellular
accumulation of amyloid-beta (Aβ) peptide in brain parenchyma and,
according to the ‘Amyloid Cascade Hypothesis’, Aβ triggers a cascade
of toxic events leading to selective synaptic and neuronal loss [1,2]. In
addition, the majority of patients with AD have cerebral amyloid
angiopathy (CAA), thus showing vascular deposition of Aβ [3] as a con-
sequence of impaired transport of Aβ across the blood–brain barrier
(BBB) [4,5]. Moreover, Aβ contributes to BBB leakage in humans with
CAA and in transgenic mice [6]. A growing body of evidences indicate
that neurovascular dysfunction occurs before the ﬁrst symptoms of
the disease and plays an important role in the neurodegenerative pro-
cess and consequent cognitive decline in AD [4,7]. Recent ﬁndings in
micemodeling ADdemonstrated thatmicrovascular impairment direct-
ly correlates with Aβ accumulation [8]. Indeed, results obtained in
human and animal cultured cells and animal isolated vessels suggest
that the age-dependent degeneration of brain vasculature and dysfunc-
tion of brain capillary endothelium is due to the toxic effects of Aβ
peptide on endothelial cells (ECs) [9–12]. In human ECs, Aβ causesCell Biology, Faculty ofMedicine,
7 Coimbra, Portugal. Tel.: +351
rdoso).irreversible morphological and functional changes that result in inhibi-
tion of their proliferative activity through accumulation of autophagic
vesicles, reduces survival and induces apoptosis [13–15]. However, the
molecular mechanisms underlying Aβ-induced endothelial dysfunction
have not been fully elucidated yet.
The endoplasmic reticulum (ER) is an organelle involved in folding
and processing of proteins in the secretory pathway and in Ca2+ ho-
meostasis. When the amount of proteins with abnormal conformation
exceeds the repair capacity of the ER, the signaling pathways of the un-
folded protein response (UPR), initiated by the ER stress sensors PERK
(protein kinase RNA-like ER kinase), IRE1 (inositol-requiring protein-
1) and ATF6 (activating transcription factor 6), are activated in order
to re-establish ER homeostasis and avoid cell damage. The UPR media-
tors lead to the transcription of genes encoding ER-resident chaperones,
such as GRP78, genes involved in ER and Golgi biogenesis, and also
genes implicated in ER-associated degradation (ERAD), attenuating
general translation to decrease the demand of ER and activate the
ERAD to degrade the aberrant proteins [16,17]. During ERAD, an ubiqui-
tin chain is added to misfolded proteins that are then retrotranslocated
to the cytosol for degradation in the proteasome [18]. However, if UPR
and ERAD fail, ER stress can also trigger the lysosome-mediated autoph-
agic protein degradation pathway to preserve cell survival [19]. In the
event of chronic or unmitigated ER stress, the UPR activates apoptotic
cascades [20].
The aim of this workwas to explore the hypothesis that Aβ damages
microvascular brain ECs through the impairment of protein quality
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to activation of apoptotic cell death pathways. Our results show that the
Aβ1–40 isoform, which accumulates in brain vasculature [21], activates
ER stress, promotes the accumulation of ubiquitinated proteins and re-
duces the proteasome activity, inhibits macroautophagy and, in the ab-
sence of compensatory mechanisms, activates apoptosis in ECs derived
from rat brain microvessels. This knowledge could contribute to the de-
velopment of novel therapeutic strategies to prevent or delay the pro-
gression of AD.
2. Materials and methods
2.1. Materials
Collagen was obtained from Roche Applied Science (Mannheim,
Germany). Mem-Alpha medium with Glutamax-1, Nut Mix F-10 W/
GLUTAMAX-1, fetal bovine serum (FBS), and geneticin were acquired
from Invitrogen Life Science (Paisley, UK). The synthetic Aβ1–40 peptide
and the Suc-Leu-Leu-Val-Tyr-AMC substrate were from Bachem
(Bubendorf, Switzerland). Boc-Leu-Arg-Arg-AMC and Z-Leu-Leu-Glu-
AMC substrates were acquired from Peptide Institute (Osaka, Japan).
Hoechst 33342 and Alexa Fluor 594 goat anti-rabbit IgG conjugate
were obtained from Molecular Probes (Leiden, The Netherlands).
Glycergel Mounting Medium was obtained from DakoCytomation Inc.
(Carpinteria, CA, USA). Colorimetric substrates for caspase-2, -3, -9, and
-12 Ac-VDAVD-pNA, Ac-DEVD-pNA, Ac-LEHD-pNA, and Ac-LEVD-pNA
were purchased from Calbiochem (Darmstadt, Germany). Polyvinylidene
diﬂuoride (PVDF) membrane, goat alkaline phosphatase-linked anti-
rabbit and anti-mouse secondary antibodies, and the enhanced
chemiﬂuorescence (ECF) reagent were acquired from Amersham
Pharmacia Biotech (Buckinghamshire, UK). Mouse monoclonal anti-
bodies reactive against GRP78 and Beclin-1 were from BD Biosciences
(Heidelberg, Germany). Rabbit polyclonal antibodies reactive against
HDAC6 and XBP-1 (spliced and unspliced form) were from Abcam plc
(Cambridge, UK). Rabbit monoclonal antibodies reactive against Bcl-2,
LC3B-XP, Aβ and rabbit polyclonal antibodies reactive against LC3B
and p62 were acquired from Cell Signaling Technology, Inc. (Danvers,
MA, USA). Mouse monoclonal antibody against glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was from Chemicon International
Inc. (Temecula, CA, USA). Mouse monoclonal anti-lysosomal-associated
membrane protein (LAMP)-1 (clone H4A3)was from the Developmental
Studies Hybridoma Bank (University of Iowa, Iowa City, IA, USA). Bio-Rad
protein dye assay reagent, acrylamide and the pre-stained Precision Plus
Protein All Blue Standard were purchased from Bio-Rad (Hercules, CA,
USA). Anti-α-tubulin mouse monoclonal antibody, Trypsin-EDTA
solution, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT), protease inhibitors (leupeptin, pepstatin A, chymostatin,
and aprotinin), phenylmethylsulfonyl ﬂuoride (PMSF), 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), Tris, sodium
dodecyl sulfate (SDS), dimethyl sulfoxide (DMSO), 1,4-dithiothreitol
(DTT), ethylene glycol tetraacetic acid (EGTA), glycerol, bromophenol
blue, NaH2PO4, ethylenediamine tetraacetic acid (EDTA), recombinant
human basic ﬁbroblast growth factor (bFGF), Tween 20, glucose,
CHAPS (3-[(3-Cholamidopropyl)-dimethylammonio]-1-propane sulfo-
nate), paraformaldehyde, phosphate-buffered saline (PBS), Coomassie
G-250, thapsigargin, NH4Cl, 3-methyladenine (3-MA), rapamycin and
lactacystin were obtained from Sigma Chemical Co. (St. Louis, MO,
USA). Bovine serum albumin (BSA), NaCl, KCl, MgCl2, CaCl2, 2-
propanol, HCl, Triton X-100, and methanol were purchased from
Merck (Darmstadt, Germany).
2.2. Cell culture and treatments
The RBE4 cell line from rat brain microvasculature was provided by
Dr. Jon Holy (University of Minnesota, Duluth, USA). It is a continuous,
immortalized cell line that retains a stable phenotype reminiscent ofBBB endothelium in vitro [22]. RBE4 cells at passages 10–35 were
grown on 75 cm2 tissue culture ﬂasks coated with 4.15 μg/cm2 colla-
gen in MEM-Alpha medium with Glutamax-1 and Nut Mix F-10 W/
GLUTAMAX-1 (1:1 vol/vol), supplementedwith 10% heat inactivated
FBS, 1 ng/ml bFGF and 0.3 mg/ml geneticin. The cultures were main-
tained at 37 °C in a humidiﬁed atmosphere of 5% CO2/95% air.
The cells were plated on collagen-coated (4.15 μg/cm2) multiwells
for cell viability,western blotting (WB) analysis ormeasurement of pro-
teasome, and caspase activities or coverslips coated with poly-L-lysine
(0.1 mg/ml) plus collagen (4.15 μg/cm2) for LC3B sub-cellular localiza-
tion or analysis of necrotic/apoptotic cell death markers, at a density
of approximately 22,000 cells/cm2, and treated with 20 mM NH4Cl,
10 mM 3-MA, 0.1 μM rapamycin, 2.5 μM Aβ1–40, 2 μM thapsigargin, or
2 μM lactacystin.
Synthetic Aβ1–40-HCl was dissolved in sterile water at a concentra-
tion of 6 mg/ml and then diluted to 1 mg/ml (231 μM) in PBS and stored
at−20 °C. Thapsigargin (non-competitive inhibitor of ER Ca2+-ATPase
that depletes Ca2+ in the ER), rapamycin (macroautophagy inducer)
and lactacystin (inhibitor of 20S proteasome) were diluted in DMSO
and stored at −20 °C until use. 3-MA (macroautophagy inhibitor)
was prepared in culture medium and NH4Cl (inhibitor of lysosomal
function by increasing the intra-lysosomal pH) was dissolved in sterile
water both immediately before use.
2.3. Measurement of protein levels by western blotting analysis
After treatments, RBE4 cells werewashed 2 timeswith PBS (pH 7.4),
lysed and scrapped in ice cold lysis buffer (in mM): 25 HEPES-Na,
2 MgCl2, 1 EDTA, 1 EGTA, supplemented with 0.1% Triton X-100,
100 μM PMSF, 2 mM DTT, and 1:1000 of a protease inhibitor cocktail
(1 μg/ml leupeptin, pepstatin A, chymostatin, and antipain). The cellu-
lar extracts were then rapidly frozen in liquid N2 and thawed three
times and centrifuged for 1 min at 106 ×g at 4 °C. The supernatant
was collected and the protein content was measured using the Bio-
Rad protein dye assay reagent. Total cellular extracts containing 15 μg
(for the ER stress markers GRP78 and XBP-1) or 50 μg (for LC3B, p62,
Beclin-1, Bcl-2, LAMP-1, HDAC6 and ubiquitin) of protein were sep-
arated by electrophoresis on 15% (for LC3B) or 10% (for other pro-
teins) (w/v) SDS-polyacrylamide gel (SDS-PAGE) after dilution (1:5)
and denaturation at 95 °C for 5 min in sample buffer (in mM): 100 Tris,
100 DTT, 4% (v/v) SDS, 0.2% (w/v) bromophenol blue, and 20% (v/v) glyc-
erol. For Aβ aggregation analysis, 40 μg of extracted cellular proteins or an
8.66 μg aliquot of the Aβ1–40 stock was separated by electrophoresis
on 4–16% Tris–Tricine SDS-PAGE [23] after dilution (1:2) in sample
buffer: 40% (w/v) glycerol, 2% (w/v) SDS, 0.2 M Tris–HCl, pH 6.8,
and 0.005% (w/v) Coomassie G-250. To facilitate the identiﬁcation of
proteins of interest, the pre-stained Precision Plus Protein All Blue Stan-
dards was used. Proteins were then transferred to PVDF membranes,
which were further blocked for 1 h at room temperature (RT) with
5% (w/v) BSA in Tris-buffered saline (150 mM NaCl, 50 mM Tris,
pH 7.6) with 0.1% (w/v) Tween 20 (TBS-T). The membranes were
next incubated overnight at 4 °C with primary mouse monoclonal anti-
bodies against GRP78 (1:1000 dilution in TBS-T), Beclin-1 (1:1000 dilu-
tion in TBS-T), LAMP-1 (1:1000dilution in TBS-T), with a primary rabbit
monoclonal antibody against Bcl-2 (1:1000 dilution in TBS-T) or β-
Amyloid (D54D2)XP® (1:200dilution in TBS-T); orwith primary rabbit
polyclonal antibodies against LC3B (1:1000 dilution in TBS-T), p62
(1:1000 dilution in TBS-T), HDAC6 (1:1000 dilution in TBS-T), or ubiq-
uitin (1:500 dilution in TBS-T). Control of protein loading was per-
formed using primary mouse monoclonal antibodies against α-tubulin
(1:20,000 dilution in TBS-T) or GAPDH (1:10,000 dilution in TBS-T).
After washing, membranes were incubated for 1 h at RT with a goat
alkaline phosphatase conjugated secondary anti-mouse or anti-rabbit
antibodies (1:20,000 dilution in TBS-T). Bands of immunoreactive pro-
teins were visualized after membrane incubation with ECF reagent for
about 5 min, on a Versa Doc 3000 Imaging System (Bio-Rad, Hercules,
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ImageJ program (Wayne Rasband, Research Services Branch, National
Institute ofMental Health, Bethesda,Maryland, USA). The ratios between
Aβ, p62, Beclin-1, Bcl-2, LAMP-1, HDAC6, or ubiquitin andGAPDH; or be-
tween GRP78, or LC3B and α-tubulin were calculated and results were
normalized to control values.
2.4. Evaluation of LC3B localization by immunocytochemistry
In order to analyze the subcellular localization of LC3B in the autoph-
agic vacuoles (AVs), treated or untreated RBE4 cells grown in glass cov-
erslips were washed three times with PBS (pH 7.4) and then ﬁxed with
4% (w/v) paraformaldehyde at RT for 20 min. After that, cells were
rinsed three times with PBS and permeabilized with 100% methanol at
−20 °C for 10 min. After washing three times with PBS the cells were
incubated for 30 min at RT in blocking solution containing 3% (w/v)
BSA in PBS to prevent non-speciﬁc binding. Subsequently, cells were in-
cubated over night at 4 °C with a primary rabbit monoclonal antibody
reactive against LC3B-XP (1:200 dilution in blocking solution). Thereaf-
ter, coverslips were rinsed in PBS and incubated for 1 h at RT with the
secondary antibody anti-rabbit IgG labeled with Alexa Fluor 594
(1:200 dilution) in PBS with 1% (w/v) BSA. Following additional rinses
in PBS, cells were stained in the dark for 5 min at RT with Hoechst
33342 (15 μg/ml) prepared in PBS. Finally, the preparations were
mounted using Glycergel Mounting Medium. Images were collected
using a Zeiss LSM 510 Meta confocal microscope (Carl Zeiss, New
York, USA) with a 63× objective. The experiments were performed
three times in duplicate, and a minimum of 150 cells was scored for
each coverslip.
2.5. Analysis of proteasomal activity
Proteasome activity wasmeasured as previously with somemodiﬁca-
tions [24]. Brieﬂy, after treatments, RBE4 cells were washed twice with
PBS, lysed and scrapped in ice cold lysis buffer (1 mM EDTA, 10 mM
Tris–HCl pH 7.5, 20% glycerol, and 4mMDTT), in the presence or absence
of 2 mM ATP to measure the activity of 26S or 20S proteasome, respec-
tively. Cells were then rapidly frozen in liquid N2 and thawed three
times and centrifuged at 13,000 ×g for 10 min, at 4 °C. Supernatants
were collected and protein concentrations were assayed using the Bio-
Rad protein dye assay reagent. Cellular extracts containing 50 μg protein
were incubated in proteasome activity buffer (0.5 mM EDTA and
50 mM Tris–HCl, pH 8.0) in the absence or presence of 400 μM Z-
Leu-Leu-Glu-AMC, 100 μM Boc-Leu-Arg-Arg-AMC, or 50 μM Suc-
Leu-Leu-Val-Tyr-AMC that are substrates of PHGH, trypsin-like, and
chymotrypsin-like proteolytic activities, respectively. The ﬂuores-
cence signals obtained with the ﬂuorogenic substrates were moni-
tored for 1 h at 37 °C in a microplate reader (SpectraMax Gemini
EM ﬂuorocytometer, Molecular Devices, California, USA) at 380 nm
excitation and 460 nm emission and the results were expressed rel-
atively to the control.
2.6. Analysis of caspase-2, -3, -9 and -12-like activity
Caspase-like activities were measured in total cellular extracts pre-
pared after treatment of ECs. Cells were washed two times with PBS at
4 °C and scrapped in reaction buffer (25 mM HEPES-Na, 10% sucrose,
10 mM DTT, and 0.1% CHAPS, pH 7.4) at 4 °C. The cellular extractsFig. 1. Intracellular Aβ in brain endothelial cells. The aggregation state of Aβ peptide, in the conc
24h (E–H)with 2.5 μMAβ1–40, 2 μMthapsigargin, 2 μM lactacystin, or 10mM3-metyladenine, a
more than 50 kDa (B and F), Aβmonomers (C and G), as well as total Aβ levels (D and H) were
SDS-PAGE and immunoblottedwith amonoclonal antibody against Aβ. An anti-GAPDHantibod
calculated relatively to control values and represent themeans±SEMof at least four independe
cells (control).were rapidly frozen and thawed three times in liquid N2, and centri-
fuged for 10 min at 20,800 ×g at 4 °C. The supernatants were collected
and assayed for protein content using the Bio-Rad protein dye assay
reagent. Aliquots of cellular extracts containing 30 μg protein were
reacted for 2 h, at 37 °C, with 0.1 mM Ac-VDAVD-pNA, Ac-DEVD-pNA,
Ac-LEHD-pNA, or Ac-LEVD-pNA, chromogenic substrates for caspase-
2, -3, -9, and -12, respectively, in reaction buffer. Caspase-2, -3, -9, and
-12-like activities were determined by measuring substrate cleavage
at 405 nm in a microplate reader (SpectraMax Plus 384) and results
were expressed relatively to the control.
2.7. Analysis of cell viability by the MTT assay
Cell viability was evaluated using the MTT assay, which measures
the ability of metabolic active cells to form formazan through cleavage
of the tetrazolium ring ofMTT. Brieﬂy, cells werewashed in sodiumme-
dium (inmM:NaCl 132, KCl 4, NaH2PO4 1.2,MgCl2 1.4, glucose 6, HEPES
10, and CaCl2 1, pH 7.4) and incubated with 0.5 mg/ml MTT for 2 h at
37 °ºC. The blue formazan crystals formed were dissolved in an equal
volume of 0.04MHCl in isopropanol and quantiﬁed spectrophotometri-
cally bymeasuring the absorbance at 570 nmusing amicroplater reader
(SpectraMax Plus 384,Molecular Devices, California, USA). Results were
expressed as the percentage of the absorbance determined in control
cells.
2.8. Data analysis
Data were expressed as means ± SEM of determinations performed
in duplicate, from at least three independent experiments. Statistical
signiﬁcance analysis was determined using one-way ANOVA followed
by Dunnett's post hoc tests or using Student's t-test. The differences
were considered signiﬁcant for P values b0.05.
3. Results
3.1. Levels of intracellular Aβ
In RBE4 cells incubated with extracellularly added Aβ1–40 for 6 h
(Fig. 1A–D) or 24 h (Fig. 1E–H) an increase in the levels of intracellular
Aβ was found, suggesting that Aβ is internalized and can potentiate its
own synthesis and/or impair its degradation in ECs. Thapsigargin-
induced ER stress, lactacystin-induced proteasomal inhibition and
macroautophagy inhibitionwith 3-MA enhanced the intracellular levels
of Aβ (Fig. 1). Moreover, a higher increase in Aβ levels, especially in
monomers and aggregates, occurred in the simultaneous presence of
these compounds and Aβ1–40 (Fig. 1A–C, E–G), in particular Aβ1–40
and thapsigargin (Fig. 1E–G). These results suggest a close relationship
between the accumulation of Aβ and the compromise of protein quality
control mechanisms in brain ECs.
3.2. ER stress in brain endothelial RBE4 cells
The activation of UPR in RBE4 cells was analyzed by measuring the
protein levels of GRP78 (Fig. 2A and B), spliced (active) and unspliced
XBP-1 (Fig. 2C–F) by WB after incubation for 6 h with 2.5 μM Aβ1–40,
2 μM thapsigargin (ER stress inducer), 2 μM lactacystin (proteasome in-
hibitor), or 10 mM 3-MA (macroautophagy inhibitor). Co-treatments
were performed simultaneously, in the absence of pre-incubation.entrated Aβ1–40 stock and inside either in untreated cells or in cells treated for 6 h (A–D) or
lone or in combination,was analyzed bywestern blot (A). The levels of aggregated Aβwith
quantiﬁed. Proteins from cell lysates (40 μg) or the Aβ stock (8.66 μg) were separated by
ywas applied as a protein loading control and used to normalize Aβ levels. The resultswere
nt experiments. *p b 0.05, **p b 0.01 and ***pb 0.001 signiﬁcantly different fromuntreated
Fig. 2. ER stress induction in brain endothelial cells. ER stresswas analyzed in treated and untreated cells bywestern blot. Proteins (15 μg) from lysates obtained from cells treatedwith 2.5 μM
Aβ1–40, 2 μM thapsigargin, 2 μM lactacystin, or 10mM 3-methyladenine alone or in combination for 6 h (in the absence of pre-treatment) were separated by SDS-PAGE and immunoblotted
with antibodies against GRP78 (A and B), unspliced (uXBP-1) and spliced (sXBP-1) forms of XBP-1 (C–F). An anti-α-tubulin antibody was applied as a protein loading control and used to
normalize protein levels of ER stressmarkers. The results were calculated relatively to control values and represent themeans± SEMof at least eight independent experiments. *p b 0.05,
**p b 0.01 and ***p b 0.001 signiﬁcantly different from control. #p b 0.05 and ##p b 0.01 signiﬁcantly different from Aβ1–40 treatment.
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signiﬁcantly increased. Enhanced GRP78 levels were detected when
cells were incubated simultaneously with Aβ1–40 and lactacystin or 3-
MA showing that Aβ1–40-induced ER stress is potentiated when accu-
mulated misfolded proteins cannot be removed by the proteasome or
macroautophagy (Fig. 2A and B). In the same way, unspliced XBP-1
(uXBP-1), which increases upon ER stress, and spliced XBP-1 (sXBP-1)
that results from XBP-1 mRNA cleavage by the ER-resident ER stress
sensor IRE1 were also enhanced by Aβ1–40 and 3-MA (Fig. 2C–F).
Taken together, these results show that Aβ1–40 triggers an ER stress re-
sponse that is potentiated by the impairment of proteostasis in brain
ECs due to inhibition of the proteasome and of lysosome-mediated
macroautophagy.3.3. UPS impairment in brain endothelial RBE4 cells
In RBE4 cells treated with 2.5 μM Aβ1–40, 2 μM thapsigargin, 2 μM
lactacystin, or 10 mM 3-MA for 6 h, ubiquitin proteasomal system
(UPS) activity was investigated through analysis of the levels of
ubiquitinated proteins by WB and measurement of the activity of the
proteasome β1, β2 and β5 catalytic subunits of the 20S core particle in
the presence (26S proteasome) or absence (20S proteasome) of ATP.
Aβ1–40, thapsigargin, lactacystin, and 3-MA increased the levels
of ubiquitinated proteins (Fig. 3A and B). Accordingly, Aβ1–40 and
thapsigargin signiﬁcantly decreased β1 (PGPH-like), β2 (trypsin-like)
and β5 (chymotrypsin-like) activities (Fig. 3C–E). 3-MA signiﬁcantly
decreased β1 and β5 activities without affecting β2 activity (Fig. 3C–E).
Fig. 3. Proteasomal dysfunction in brain endothelial cells. (A and B) The levels of ubiquitinated proteins in RBE4 cells treatedwith 2.5 μMAβ1–40, 2 μM thapsigargin and 2 μM lactacystin for 6 h
were analyzed bywestern blot. Proteins (50 μg) from cell lysates were separated by SDS-PAGE and immunoblotted with a polyclonal antibody against ubiquitin. An anti-GAPDH antibodywas
applied as a protein loading control and used to normalize levels of ubiquitinated proteins. (C–E)Moreover, the activity ofβ1 (C),β2 (D) andβ5 (E) catalytic subunits of proteasomeweremea-
suredwith (26S proteasome) orwithout (20S proteasome)ATP after 6 h incubation of RBE4 cellswith 2.5 μMAβ1–40, 2 μMthapsigargin, 2 μM lactacystin, or 10mM3-metyladenine. The results
were calculated relatively to control values and represent themeans± SEM of at least four independent experiments. *p b 0.05, **p b 0.01 and ***p b 0.001 signiﬁcantly different from control.
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proteins, indicating a direct role in the alteration of proteostasis
mechanisms. Furthermore, our data show that macroautophagy in-
hibition is not compensated by activation of proteasome-mediated
degradation.
3.4. Autophagy in brain endothelial RBE4 cells
To evaluate whether Aβ1–40, ER stress and proteasome inhibition
upregulated macroautophagy in RBE4 cells, as a compensatory mecha-
nism, we determined the LC3-II/α-tubulin ratio and the LC3 punctuate,
which directly correlates with the amount of autophagosomes [25], by
WB and immunocytochemistry, respectively, after treatment with
Aβ1–40 (2.5 μM), thapsigargin (2 μM) or lactacystin (2 μM) for 6 h
(Fig. 4A, B and D). Only lactacystin increased signiﬁcantly the
basal LC3-II/α-tubulin ratio (Fig. 4A and B). NH4Cl, which changes
the pH inside the lysosomes leading to inhibition of lysosome-
resident hydrolases, was used to evaluate the lysosomal degradation
of autophagosomes' cargo (autophagic ﬂux). As expected, a signiﬁcant
increase in the LC3-II/α-tubulin ratio was determined in cellsstimulated with Aβ1–40, thapsigargin or lactacystin in the presence of
NH4Cl (Fig. 4A and B) and the calculated ratio between levels measured
in the presence and absence of NH4Cl, which corresponds to the au-
tophagic ﬂux, decreased approximately 32%, 47%, and 55%, respectively,
in Aβ1–40-, thapsigargin-, or lactacystin-treated cells compared to un-
treated cells (Fig. 4C). These data indicates that macroautophagy does
not compensate for the loss of proteostasis under ER stressful condi-
tions or compromised proteasome-mediated protein degradation.
As the p62protein is able to bind LC3 in autophagosomes, its amount
is frequently used as amarker of autophagic ﬂux. p62 protein levels sig-
niﬁcantly increased with NH4Cl treatment but Aβ1–40 or thapsigargin
didn't change signiﬁcantly the levels of p62. However, proteasomal in-
hibition with lactacystin signiﬁcantly increased p62 levels (Fig. 4E
and F).
Beclin-1 is involved in the formation of autophagic vesicles and its
activity is regulated by interaction with Bcl-2. Therefore, the protein
levels of Beclin-1 and Bcl-2 were analyzed by WB in total and cytosolic
cellular extracts in the experimental conditions described above. Al-
though thapsigargin slightly decreased Beclin-1, but not Bcl-2 levels,
Aβ1–40, thapsigargin or lactacystin was not able to signiﬁcantly change
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(data not shown) extracts, which means that autophagic induction is
not compromised in this cells.
HDAC6 is involved in recruitment of cargo autophagic proteins to
be degraded and is also implicated in the lysosomal dynamics [26].
Therefore, HDAC6 levels were analyzed by WB but signiﬁcant changes
were not found between controls and treated cells (Fig. 4E and I).
Lamp1 protein levels, analyzed by WB, were used as lysosomal
markers after incubation of RBE4 cells with Aβ1–40, thapsigargin or
lactacystin, in the absence or presence of NH4Cl. As expected, the inhibi-
tion of lysosomeswith NH4Cl increased the amount of Lamp1, ameasure
to compensate for lysosomal loss of function. Aβ1–40 did not affect Lamp1
levels while thapsigargin and lactacystin led to a signiﬁcant decrease in
Lamp1 (Fig. 4E and J). A decrease in the levels of Lamp1 measured in
the presence of NH4Cl in Aβ-, thapsigargin- or lactacystin-treated cells
was observed demonstrating that the compensatory lysosomal biogene-
sis triggered by NH4Cl is compromised. All together, these ﬁndings indi-
cate that macroautophagy is compromised in brain ECs treated with
Aβ1–40 or exposed to ER stress conditions or proteasome dysfunction,
mainly due to inhibition of autophagic ﬂux.
3.5. Moderate ER stress stimulates macroautophagy in brain endothelial
RBE4 cells
In order to analyze the effect of moderate ER stress on
macroautophagy, RBE4 cells were treated for 6 h with low doses of
thapsigargin, 25 and 50 nM, and co-treated with 20 mM NH4Cl in the
last 4 h of incubation. Both concentrations of thapsigargin increased
the protein levels of the ER stress marker GRP78 (Fig. 5A and B) show-
ing that low thapsigargin levels were able to induce ER stress and acti-
vate the UPR. At a concentration of 50 nM, thapsigargin enhanced the
levels of the macroautophagy marker LC3-II (Fig. 5A and C) but the au-
tophagic ﬂuxwas not affected compared to untreated ECs in the presence
of both tested thapsigargin concentrations (Fig. 5D). In conclusion, amod-
erate induction of ER stress can stimulate macroautophagy, which might
represent an attempt of ECs to restore homeostasis.
3.6. Apoptosis in brain endothelial RBE4 cells
After 12 h of treatment with Aβ1–40 (2.5 μM), thapsigargin (2 μM),
lactacystin (2 μM), or 3-MA (10 mM), the activity of caspase-2, -3, -9,
and -12 was quantiﬁed in cellular extracts prepared from RBE4 cells. 3-
MA and Aβ1–40 signiﬁcantly activated all caspases analyzed, thapsigargin
activated all caspases except caspase-2 and lactacystin only signiﬁcantly
increased caspase-2 activity (Fig. 6A–D). Similar results were obtained
after 6 and 24 h of treatment (data not shown).
After incubation of RBE4 cells during 12 h with Aβ1–40 (2.5 μM),
thapsigargin (2 μM), or 3-MA (10 mM), a signiﬁcant decrease in cell
survival, as measured by the MTT test, was detected. Moreover, the
co-incubation with Aβ1–40 and 3-MA further decreased cell survival,
as compared with 3-MA or Aβ1–40 alone (Fig. 6E). Additionally, the
co-incubation of ECs with 0.1 μM rapamycin and Aβ1–40 (2.5 μM),
thapsigargin (2 μM) or lactacystin (2 μM) for 12 h partially reverted
the decrease in cell viability induced by Aβ1–40 or thapsigargin alone,
but not by lactacystin (Fig. 6F). In conclusion, the impairment of pro-
tein quality control mechanisms leads to caspase-dependent apo-
ptotic cell death in brain ECs.Fig. 4.Macroautophagy deregulation in brain endothelial cells. RBE4 cells were incubated for 6
20 mM NH4Cl. The protein levels of LC3-I (A), LC3-II (A and B), p62 (E and F), Beclin-1 (E an
blot. Proteins (50 μg) from cell lysates were separated by SDS-PAGE and immunoblotted with
loading controls and used to normalize the levels of the analyzed proteins. Furthermore, the ra
imental condition was calculated in order to analyze the autophagic ﬂux (C). The results were
dependent experiments. *p b 0.05, **p b 0.01 and ***p b 0.001 signiﬁcantly different from
followed by immunocytochemistry using a speciﬁc antibody against LC3B and Hoechst 33342
using a confocal microscope. Selected ﬁelds in merged images (white squares) were ampliﬁed4. Discussion
RBE4 cells are commonly used as an in vitromodel of the ECs present
at the BBB [27], which protect the central nervous system, acting as
ﬁlters for molecules and microorganisms and also synthesizing neu-
rotrophic factors. Therefore, alterations in the survival of these cells
play a major role in several neurological disorders. In particular,
neurovascular dysfunction arising from the toxic effects of Aβ on
brain ECs has been implicated in the cognitive decline occurring in
AD [4]. Previously, we have shown that Aβ1–40 induces ER stress
and consequently activates the UPR and deregulates ER Ca2+ homeo-
stasis, both in rat brain cortical neurons and in ECs, leading to activation
of mitochondrial-dependent and -independent apoptotic cell death
pathways [28,29]. Here we further investigated the toxic effects of Aβ
on brain ECs, using RBE4 cells as an in vitromodel, through the analysis
of protein quality control mechanisms in the secretory pathway (ER
stress-induced UPR) and in the cytosol (UPS, and macroautophagy). In
parallel, we tested the effect of well-known modulators of the cellular
mechanisms involved in proteostasis, namely thapsigargin (ER stress in-
ducer), lactacystin (proteasome inhibitor), and 3-MA (macroautophagy
inhibitor). The ubiquitin–proteasome and the autophagy–lysosome sys-
tems are two major protein degradation pathways that can be activated
in eukaryotic cells when the ER fails to repair unfolded ormisfolded pro-
teins, preventing cell death. However, apoptotic cell death can be trig-
gered when these mechanisms are not able to cope with the excessive
accumulation of abnormal proteins.
In thiswork, exposure to extracellular Aβ1–40, aswell as perturbation
of protein quality control mechanisms (ER stress, inhibition of UPS and
inhibition of macroautophagy) were shown to increase the levels of Aβ,
mainly monomers and aggregates in the brain ECs. These results, ob-
tained in RBE4 cells co-treated with Aβ1–40 and quality control inhibi-
tors indicate that exogenous Aβ can be internalized and potentiate its
own accumulation, through inhibition of proteostatic pathways. In
fact, Aβ can be internalized by ECs in the BBB regulating the efﬂux and
inﬂux of Aβ to the brain [30,31]. Furthermore, the accumulation of
AVs and ER stress, which delays the transport of proteins along the se-
cretory pathway, can increase Aβ production by enhancing the expo-
sure of amyloid precursor protein (APP) to β- and γ-secretases, which
are more abundant in the ER, Golgi and endosomes than in the plasma
membrane [32–34]. ER stress was previously shown to increase
β- and γ-secretase activities enhancing Aβ production [35,36].
Hence, the signiﬁcant increase of Aβmonomers in ECs co-treated with
Aβ1–40 and thapsigargin, compared to Aβ alone, suggest that Aβ pro-
duction is increased under ER stress. Since aggregated Aβ is degrad-
ed by macroautophagy in physiological conditions, the impairment
in macroautophagy reduces the degradation of Aβ [32]. Additionally,
an increase in total Aβ levels can potentiate its aggregation [37]. Ac-
cordingly, ECs treated with Aβ1–40 alone or in combination with an
ER stress inducer, proteasome or autophagy inhibitor, increased the
levels of Aβ aggregates with a molecular weight higher than 50 kDa.
As expected, Aβ1–40 and the inhibition of proteasome and
macroautophagy activated the UPR since accumulation of abnormal
proteins can induce ER stress. These proteins can also be degraded in
the proteasome. However, Aβ1–40, as well as thapsigargin, increased
the amount of polyubiquitinated proteins suggesting that damaged
proteins, targeted for degradation in the proteasome, are not efﬁciently
removed. Accordingly, the activity of β1, β2 and β5 catalytic subunits ofh with 2.5 μM Aβ1–40, 2 μM thapsigargin or 2 μM lactacystin and co-treated for 4 h with
d G), Bcl-2 (E and H), HDAC6 (E and I) and Lamp1 (E and J) were analyzed by western
the speciﬁc antibodies. Anti-α-tubulin or anti-GAPDH antibodies was applied as protein
tio between LC3-II levels measured in the presence and absence of NH4Cl, for each exper-
calculated relatively to control values and represent the means ± SEM of at least four in-
control. (D) In addition, the subcellular distribution of LC3B protein in RBE4 cells was
to label nuclei and the ﬂuorescence images of control and treated cells were visualized
images.
Fig. 5. Autophagy under moderate ER stress conditions. Proteins in cellular lysates from
RBE4 cells treated with 25 or 50 nM thapsigargin during 6 h and co-treated with NH4Cl
for 4 h were separated by SDS-PAGE and immunoblotted with antibodies against GRP78
(A and B) or LC3B (A and C). In order to analyze the autophagic ﬂux, the ratio between
LC3-II levels calculated in cells treated with 25 or 50 nM thapsigargin in the presence
and absence of NH4Cl was determined (D). An anti-α-tubulin antibodywas applied as a pro-
tein loading control and used to normalize protein levels of ER stress and macroautophagy
markers. The results were calculated relatively to control values and represent the
means ± SEM of at least eight independent experiments. **p b 0.01 and ***p b 0.001 sig-
niﬁcantly different from control.
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These results are in agreementwith results obtained by Nijholt and col-
laborators that found diminished activity of β2 and β5 subunits of pro-
teasome in neuronal cells in the presence of the ER stress inducer
tunicamycin [38]. This inhibition of proteasome can be due to the exces-
sive accumulation of aggregated misfolded proteins resulting from ER
stress that block the proteasome. Other authors reported that soluble
Aβ oligomers inhibit the activity of the proteasome [39] and ﬁbrillar
Aβ1–40 was shown to impair proteasomal activity through the increase
expression of the E2 ubiquitin-conjugating enzyme E2-25K/Hip2 lead-
ing to a proteolytic activation of ER-resident caspase-12 in the brains
of Tg2576 and APPswe/PS1dE9 mice [40]. Furthermore, impairment in
proteasome function but not expression of proteasome subunits has
been described in the brain of AD patients [41,42]. Under conditions
of proteasome inhibition, cytotoxic proteins such as tau and Aβ accu-
mulate, promoting the formation of inclusion bodies [39,43]. In mouse
neuroblastoma N2a cells, the accumulation of cytoplasmic prion aggre-
gates inside the cells leads to ER stress, impairment of UPS and induc-
tion of autophagy and apoptosis [44], supporting a close relationship
between impaired protein quality control mechanisms and activation
of cell death. More recently, protein aggregates resulting fromproteasome dysfunction were shown to upregulate LC3-II in rat
brain oligodendrocytes [45]. This increase in LC3-II, also observed
in human ECs [15], can be due to an increase in macroautophagy in-
duction or to an impairment of autophagosome degradation.
Macroautophagy plays an important role in removing protein aggre-
gates andorganelles that are not degraded by theUPS [46]. Dysfunction-
al macroautophagy results in the accumulation of ubiquitinated and
aggregated proteins and damaged organelles [47]. Autophagosomes
were shown to accumulate in the brain of AD patients [47]. Our data
suggest that, in the brain endothelium, this accumulation can be due
to a decrease in autophagic ﬂux induced by Aβ due to excessive or
sustained ER stress or proteasome inhibition. A functional autophagy
is needed for the clearance of large polyubiquitinated proteins [48]. A link
between ubiquitinated proteins and the autophagic machinery to enable
degradation in the lysosome is p62which binds to polyubiquitinated pro-
teins co-localizes with ubiquitinated protein aggregates in numerous
neurodegenerative diseases and also binds to LC3 [49,50]. Recent evi-
dences demonstrate that p62 has an important role in AD since it is in-
volved in the degradation of tau [51]. p62 is used as an autophagic ﬂux
marker because it could accumulate when autophagic ﬂux is inhibited
[52]. However, it is also involved in proteasome-mediated degradation
and accumulates when proteasome is inhibited [53], which makes the
use of p62 as a generalmarker of autophagy a questionable issue. Accord-
ingly, p62 protein levels were not signiﬁcantly altered after incubation of
RBE4 cells with Aβ1–40 or thapsigargin, but increased when proteasome
activity was inhibited showing that proteasome is important for p62 deg-
radation. Previously, we found that Aβ1–40 and thapsigargin increase ROS
production in RBE4 cells (data not shown). Indeed, oxidative damage to
the p62 promotor reduces p62 expression that is in accordance with the
decreased levels of p62 in the brain of AD patients [54,55]. This decrease
can compensate any increase in p62 protein levels due to the inhibition
of autophagy ﬂux induced by Aβ1–40 and thapsigargin.
The increase in ROS production, as well as the rise in cytosolic Ca2+
concentration and UPR activation, which were demonstrated to be in-
duced by Aβ1–40 in RBE4 cells [29], are able to boost macroautophagy
in neurons and neuron-like cells [56,57]. However, the levels of Beclin-1
and Bcl-2 were not signiﬁcantly altered by Aβ1–40, thapsigargin, or
lactacystin suggesting that the activation step in the macroautophagic
pathway is not affected or up-regulated by Aβ1–40, ER stress, or protea-
some inhibition in this type of cells.
When the formation of inclusion bodies overwhelms its clearance,
the protein aggregates are transported to microtubule-organizing cen-
ter (MTOC)-associated aggresomes. This process requires HDAC6 that
[58,59] binds to dynein to transport polyubiquitinated misfolded pro-
teins along microtubules to the aggresome that are then recognized
by the autophagosome [58]. HDAC6 is also involved in lysosomal dy-
namics [26]. Thus, a decrease in HDAC6 protein levels can reduce au-
tophagic ﬂux. Nevertheless, its levels were not altered by Aβ1–40,
thapsigargin, or lactacystin, and thus the observed reduction of autoph-
agic ﬂux with these conditions must be independent of HDAC6.
Previously we showed that Aβ inhibits autophagic ﬂow in a human
neuroblastoma SH-SY5Y cell line [60]. These alterations were due to
Aβ-induced mitochondria dysfunction, which causes microtubule dis-
ruption and consequent inhibition of the transport of autophagosomes
and lysosomes. Consequently, autophagosome degradation was de-
creased. Interestingly, the use of the microtubule stabilizer taxol re-
duced mitochondrial and cytosolic Aβ levels [60] showing that Aβ
can be degraded by macroautophagy. Since ER stress triggered by
Aβ1–40 or thapsigargin induces mitochondria dysfunction through
ER-to-mitochondria Ca2+ transfer [61–64], we can hypothesize that
ER stress can causemicrotubule disruption and subsequently affects au-
tophagy ﬂux. The 26S proteasome is involved in the formation and
restructuration of microtubules [65]. Hence, the observed inhibition of
proteasome by Aβ1–40 or thapsigargin or by lactacystin can impair the
functioning of microtubules and consequently reduce the transport of
AVs and lysosomes. On the other hand, dysfunctional microtubules
Fig. 6. Apoptosis in brain endothelial cells. RBE4 cells were treated with 10 mM 3-MA, 2.5 μM Aβ1–40, 2 μM thapsigargin or 2 μM lactacystin for 12 h and caspase-2 (A), caspase-3
(B), caspase-9 (C) and caspase-12 (D) -like activities were determined in cell lysates (30 μg of protein) using the colorimetric substrates Ac-VDAVD-pNA, Ac-DEVD-pNA, Ac-LEHD-pNA
and Ac-LEVD-pNA, respectively. Moreover, cell viability in ECs treated with 2.5 μM Aβ1–40, 2 μM thapsigargin or 2 μM lactacystin, with or without 0.1 μM rapamycin or 10 mM 3-MA,
for 12 h was analyzed by measuring the capacity of the cells to reduce MTT (E). The presented results were normalized to control and represent the means ± SEM of at least three inde-
pendent experiments performed in duplicate. *p b 0.05, **p b 0.01 and ***p b 0.001 signiﬁcantly different from control, ##p b 0.01 and ###p b 0.001 signiﬁcantly different from Aβ1–40
treatment, $$p b 0.01 signiﬁcantly different from 3-MA treatment and &&p b 0.01 signiﬁcantly different from thapsigargin treatment.
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vation of the UPR decreases general protein translation in order to re-
duce ER stress [67]. A strong or prolonged activation of the UPR can
signiﬁcantly diminish the amount of crucial proteins. Consequently,
the function or the number of speciﬁc organelles, especially those de-
pendent on the secretory pathway, can be diminished. In accordance,
the treatment of RBE4 cells with thapsigargin or lactacystin reduced
the levels of lysosomes, which impair the capacity of the cells to de-
grade autophagosomes, as demonstrated by the reduction in autoph-
agic ﬂux.
Contrarily to severe ER stress induced by high thapsigargin levels
that impaired macroautophagy, moderate ER stress induced by lower
doses of thapsigargin was shown to stimulatemacroautophagywithout
affecting the autophagic ﬂux, possibly as a compensatorymechanism to
degrade abnormal proteins, as demonstrated previously [68].
Under normal conditions, autophagy andUPS have an anti-apoptotic
effect because the clearance of soluble and aggregated misfolded pro-
teins is enhanced [57]. Since Aβ1–40 inhibited macroautophagy and the
proteasome in RBE4 cells, damaged proteins and organelles resulting
from Aβ1–40-induced ER stress were not repaired and accumulated, fur-
ther enhancing ER stress. In addition, excessive ER stress triggers apopto-
sis through several pathways such as the elevation of ROS and cytosolic
Ca2+ levels, activation of the ER-resident caspase-12, upregulation of
the pro-apoptotic CHOP, release of cytochrome c from mitochondriaand consequent activation of caspase-9 and -3 as observed in the present
study [29,69]. Moreover, caspase-2 was activated by Aβ1–40 and
lactacystin but not by thapsigargin. This caspase is localized at the
Golgi complex and also promotes the translocation of Bax to mito-
chondria and consequent permeabilization of mitochondria and cy-
tochrome c release upon genotoxic stress or JNK activation [70–72].
3-MA, a well-known inhibitor of macroautophagy, increased Aβ
levels inside RBE4 cells, induced ER stress, decreased proteasomal activity
and robustly activated caspases leading to cell death by apoptosis. This
was probably due to an increased accumulation of damaged proteins
and organelles that were not efﬁciently degraded by macroautophagy.
Aβ can be degraded by macroautophagy but this peptide can also
be generated within endosomes and in autophagosomes when lyso-
somal degradation is compromised [34,60,73]. Despite the fact that
Aβ1–40, thapsigargin and lactacystin did not signiﬁcantly induce
macroautophagy, autophagosome accumulation due to a decrease
in their turnover can potentiate the formation of Aβ. In addition,
macroautophagy activation by 1 μM rapamycin was not able to revert
the effects of Aβ1–40, thapsigargin and lactacystin (data not shown),
but 0.1 μM rapamycin partially reverted the loss of viability induced
by Aβ1–40 and thapsigargin. These ﬁndings demonstrate that severe in-
duction of macroautophagy is toxic to ECs, probably through an exces-
sive accumulation of autophagosomes that the cells cannot eliminate,
but a slight/moderate activation of macroautophagy can compensate
Fig. 7. Apoptosis triggered by Aβ1–40-through deregulation of proteostasis in brain endothelial cells. ER stress caused by Aβ leads to the accumulation of misfolded proteins that can be
targeted for degradation in the proteasome or in the lysosome by macroautophagy when become aggregated. However, oligomeric and large protein aggregates block the proteasome
and further induce ER stress. Under conditions of severe ER stress, general protein translation is inhibited and impairs ER functioning, compromising the biogenesis of organelles, such
as the lysosome. As a consequence, the degradation of autophagosomes' cargo decreases and protein aggregates accumulate. Therefore, ER stress and proteasome blockage are exacerbat-
ed, leading to cell death by apoptosis. Similarly, the inhibition of autophagosome formation by 3-methyladenine (3-MA), the inhibition of the proteasome by lactacystin, and the induction
of ER stress by thapsigargin increase the accumulation of aggregated proteins and consequently impair protein quality control and induce apoptosis.
1160 A.C. Fonseca et al. / Biochimica et Biophysica Acta 1843 (2014) 1150–1161the toxic effects arising from deregulation of proteostasis by degrading
damaged proteins and organelles.
5. Conclusion
Our ﬁndings support the idea that Aβ1–40 induces ER stress and im-
pairs proteasomal activity in brain ECs. The inhibition of the proteasome
in turn potentiates ER stress and the accumulation of abnormal proteins
can aggregate and be targeted for degradation by macroautophagy
within the lysosome. However, sustained and excessive ER stress in-
creases the amount of dysfunctional abnormal proteins, reduces de
novo protein synthesis that can impair the biogenesis of lysosomes, ac-
tivates ER stress-dependent apoptotic pathways and also deregulates
Ca2+ homeostasis. Due to the close crosstalk between the ER andmi-
tochondria, this later organelle is also affected, and ATP production
decreases, which may deplete vesicular transport, subsequently
compromising autolysosome formation, and mitochondria-dependent
apoptotic pathways are activated. As a result, the ECs die by apoptosis
(Fig. 7), which can contribute to the dysfunction of the BBB found in AD.
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